[Strategy for cardiac arrhythmias in acute coronary syndrome]
1Division of Cardiovascular Medicine, Toho University Ohashi Medical Center.
Insights
Acute coronary syndrome can cause dangerous heart rhythms like ventricular tachycardia and atrial fibrillation. Potassium channel blockers are increasingly used to prevent these arrhythmias, with specific drug choices depending on the type.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Context:
- Acute coronary syndrome (ACS) is frequently associated with cardiac arrhythmias due to myocardial ischemia and electrical instability.
- Ventricular tachycardia (VT) is a critical arrhythmia in ACS, potentially degenerating into ventricular fibrillation (VF), necessitating immediate intervention.
- Atrial fibrillation (AF) also occurs in ACS patients, often worsening hemodynamic stability.
Purpose:
- To discuss the management of arrhythmias in acute coronary syndrome.
- To highlight the role of potassium channel blockers in preventing ventricular tachyarrhythmias.
- To outline therapeutic options for preventing and terminating atrial fibrillation in the context of ACS.
Summary:
- Acute coronary syndrome (ACS) leads to arrhythmias, primarily ventricular tachycardia (VT) progressing to ventricular fibrillation (VF), requiring direct current cardioversion.
- Potassium channel blockers, such as nifekalant and amiodarone, are increasingly utilized in Japan for preventing VT/VF.
- Atrial fibrillation (AF) in ACS can compromise hemodynamics; drugs like aprindine, amiodarone, or bepridil are options for post-cardioversion prevention.
Impact:
- Provides guidance on selecting antiarrhythmic drugs for managing life-threatening arrhythmias in acute coronary syndrome.
- Emphasizes the importance of preventing recurrent arrhythmias to improve patient outcomes and stability.
- Contributes to the understanding of pharmacological strategies for cardiac rhythm management in ACS patients.
Abstract:
Acute coronary syndrome causes several types of arrhythmia because of its electrical instability and ischemia. The most important arrhythmia is ventricular tachycardia which degenerates to ventricular fibrillation. Prompt direct current cardioversion will be needed and prevention of ventricular tachyarrhythmia by potassium channel blocker became more popular in Japan. Nifekalant or amiodarone should be selected. Atrial fibrillation also occurred in the patients with acute coronary syndrome, and it may deteriorate hemodynamics condition. Therefore, termination and prevention of atrial fibrillation is another important issue in acute coronary syndrome. Aprindine, amiodarone, or bepridil will be the choice to prevent recurrent atrial fibrillation after direct current cardioversion.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome V: Nursing Management
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias


